SCHEMBL6563885

SCHEMBL6563885

Ic1cccc(Cc2cc(I)cc(I)c2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.52
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
THPO P40225 1/20 0.47
RAB9A P51151 1/20 0.47
HIF1A Q16665 1/20 0.47
LMNA P02545 1/20 0.41
PMP22 Q01453 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CALM1 P0DP23 1/20 0.38
SIGMAR1 Q99720 2/20 0.37
TACR1 P25103 1/20 0.37
AKT1 P31749 1/20 0.35
IDH1 O75874 1/20 0.34
PRSS1 P07477 1/20 0.34
PRSS2 P07478 1/20 0.34
PRSS3 P35030 1/20 0.34
MAPK8 P45983 1/20 0.33
CDC7 O00311 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9352538 0.93 IDO1 (0.58) IDO1CYP1A2CYP2D6CYP2C19THPO
SCHEMBL26149603 0.86 CALM1 (0.57) IDO1CYP1A2CYP2D6CYP2C19THPO
SCHEMBL22560098 0.86 IDO1 (0.44) IDO1CYP1A2CYP2D6CYP2C19THPO
SCHEMBL9348618 0.84 IDO1 (0.50) IDO1CYP1A2CYP2D6CYP2C19THPO
SCHEMBL6512036 0.82 TTR (0.33) IDO1CALM1
SCHEMBL22679406 0.80 TAAR1 (0.48) IDO1CYP1A2CYP2D6CYP2C19THPO
SCHEMBL28131040 0.80 TAAR1 (0.48) IDO1CYP1A2CYP2D6CYP2C19THPO
SCHEMBL20691033 0.79 IDO1 (0.46) IDO1CYP1A2CYP2D6CYP2C19THPO
SCHEMBL32665334 0.79 ESR1 (0.56) IDO1CYP1A2CYP2D6CYP2C19THPO
SCHEMBL13547721 0.79 CYP17A1 (0.46) IDO1CYP1A2CYP2D6CYP2C19THPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1404413-A2 DERMATOLOGICAL FORMULATIONS KARO BIO AB (SE) 2004-04-07 EP claimed
EP-1328265-A2 NOVEL USES FOR THYROID HORMONES OR THYROID HORMONE-LIKE AGONIST COMPOUNDS FOR TREATING DERMIS CONDITIONS KARO BIO AB (SE) 2003-07-23 EP claimed
WO-2002089917-A2 DERMATOLOGICAL FORMULATIONS KARO BIO AB (SE) 2002-11-14 WO claimed
WO-2002005834-A2 NOVEL USES FOR THYROID HORMONES OR THYROID HORMONE-LIKE AGONIST COMPOUNDS FOR TREATING DERMIS CONDITIONS KARO BIO AB (SE) 2002-01-24 WO claimed
EP-1328265-A2 NOVEL USES FOR THYROID HORMONES OR THYROID HORMONE-LIKE AGONIST COMPOUNDS FOR TREATING DERMIS CONDITIONS KARO BIO AB (SE) 2003-07-23 EP disclosed
WO-2002005834-A2 NOVEL USES FOR THYROID HORMONES OR THYROID HORMONE-LIKE AGONIST COMPOUNDS FOR TREATING DERMIS CONDITIONS KARO BIO AB (SE) 2002-01-24 WO disclosed
WO-1996040048-A9 NOVEL USES FOR THYROID HORMONES OR THYROID HORMONE-LIKE COMPOUNDS 1997-03-27 WO disclosed